Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 9134
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
51980
We got the phase3 go ahead. We are looking at
(3)
williamsc
12/17/2018 11:04:33 AM
51979
I think we would know about a partner within
Squar
12/17/2018 10:57:50 AM
51978
Volume too low
Jimmyboy
12/17/2018 10:40:08 AM
51977
Agreed.......with Dr.Mennon leaving or asked to
(4)
tryz
12/17/2018 10:35:42 AM
51976
I'm thinking we'll see more news either today or
(5)
BooDog
12/17/2018 10:05:33 AM
51975
I've heard no discussion yet of where the funds
(6)
scgmck1
12/17/2018 10:01:09 AM
51974
Trying to decide what to do this morning with
Squar
12/17/2018 9:47:54 AM
51973
Depends on the offer.
Trading Pro Broker
12/17/2018 9:33:53 AM
51972
Well, it looks TheDane is right. Prurisol was
Squar
12/17/2018 9:33:07 AM
51971
What I find most interesting is that the proposed
(6)
Ultimate
12/17/2018 9:28:22 AM
51970
Who knows, P is out the window, and B is going to
Commando911
12/17/2018 9:20:59 AM
51968
I don't believe P was thought to be a long shot
(1)
Squar
12/17/2018 9:17:11 AM
51967
Doubt any sell out happens. Partnerships has
(1)
Jimmyboy
12/17/2018 9:14:28 AM
51966
Expect a full court press by the minions of the
(3)
AlanC
12/17/2018 9:13:15 AM
51965
Agreed, P was a long shot. Everyone here has
Jimmyboy
12/17/2018 9:08:37 AM
51964
Any other 8-Ks today? Anyone?
ThePorchPirate
12/17/2018 9:05:07 AM
51963
Well now that we know all the trial results all
(1)
Squar
12/17/2018 9:04:18 AM
51962
People resign when their services are no longer
Drano
12/17/2018 9:03:02 AM
51961
I kind of saw this coming, Menon went to 1/2 pay
zdubble17
12/17/2018 9:02:31 AM
51959
Untruth is grounds for deletion. Replies to
(1)
Drano
12/17/2018 8:58:22 AM
51958
The P trial failed which from data presented we
Trading Pro Broker
12/17/2018 8:57:43 AM
51956
There were two 8-Ks filed 12/17. The first was
Squar
12/17/2018 8:55:28 AM
51954
I am guessing this qualifies as a successful EOP
Trading Pro Broker
12/17/2018 8:38:04 AM
51953
I see it now on the 8K
zdubble17
12/17/2018 8:37:24 AM
51950
you are right again agree with you on both as
aragon1959
12/17/2018 8:25:12 AM
51949
It may be that they have the formulation done
(2)
Drano
12/17/2018 8:08:49 AM
51948
you are right Drano They must have this
aragon1959
12/17/2018 8:04:59 AM
51947
Don't you think this means they've got the
(1)
Drano
12/17/2018 7:58:51 AM
51946
Our interactions with the FDA have been highly
(1)
Drano
12/17/2018 7:54:46 AM
51945
Head and Neck cancer is 6th most common It should
(1)
aragon1959
12/17/2018 7:53:30 AM
51944
How many patients and what is duration for phase
Zadie
12/17/2018 7:29:47 AM
51943
On to phase 3....
Commando911
12/17/2018 7:08:32 AM
51942
https://mailchi.mp/ipharminc/innovation-pharmaceu
(1)
Commando911
12/17/2018 7:08:02 AM
51941
Innovation Pharmaceuticals Completes End-of-Phase
Commando911
12/17/2018 7:06:46 AM
51940
Thats it
Trading Pro Broker
12/17/2018 12:08:58 AM
51939
It was posted Sunday December 16 along with a
(1)
Jimmyboy
12/16/2018 11:15:57 PM
51935
Like I said, borderline personality disorder
(1)
Drano
12/16/2018 10:17:21 PM
51934
$500 million to $1.3 billion would be my wild
Squar
12/16/2018 9:56:53 PM
51933
https://rumormu
(1)
Squar
12/16/2018 9:54:45 PM
51932
I think we all know that Leo expects stellar #'s
Kelt
12/16/2018 9:18:51 PM
51931
The problem is there have been so many rumors on
TheDane
12/16/2018 9:12:11 PM
51930
Thanks for the link. Now we have something to
(1)
Drano
12/16/2018 9:07:28 PM
51929
Interesting that we have seen some pumpers coming
Drano
12/16/2018 9:04:09 PM
51928
Here it is...looks like 4:58 p.m. today...
TheDane
12/16/2018 9:02:45 PM
51927
This rumor in the link could be weeks or days
TheDane
12/16/2018 8:59:59 PM
51926
Is this the site? The problem is there is no date
TheDane
12/16/2018 8:58:48 PM
51925
What website?
TheDane
12/16/2018 8:47:53 PM
51924
Updated rumor IPIX accepts buyout offer from
Trading Pro Broker
12/16/2018 8:36:37 PM
51923
Not "sway" but all to do with B being an
williamsc
12/16/2018 8:30:14 PM
51922
A sign of pathological liars, and of people with
(1)
Drano
12/16/2018 8:20:33 PM
Newer
Older
Recent Articles
Innovative Partnership: Xpore and Patagonia's Sustainable Journey
Wayfyndr Unveils Enhanced Fan Engagement with New Partners
FEMSA's New Leadership: A Vision for Strategic Growth
Investors Rally for Replimune: An Opportunity for Recovery
Cryptocurrency Market Insights: Rate Cuts and Price Predictions
Exploring the EBSCO Scholarly Graph: A New Era for Research
Innovative Collaboration for Autonomous Construction Tech
FEMSA's New CEO: A Vision for Future Growth and Sustainability
Flywire Investors: Legal Insights on Upcoming Claims and Deadlines
Investigation Launched into PubMatic by Faruqi & Faruqi, LLP
Cathie Wood's Investment Moves: Bullish Trends and Strategic Exits
Garmin Collaborates with Meta to Enhance AI Glasses Performance
EssilorLuxottica and Meta Unveil Next-Gen AI Glasses in 2025
Chenghe Acquisition III Co. Successfully Completes IPO Raising $126.5 Million
Investor Alert: Tronox Holdings Faces Legal Scrutiny
New Investigations Open for SelectQuote Investors Amid Concerns
CAIXA ECONÔMICA FEDERAL Sees Tremendous Growth in 2025
Celebrating Upcoming Leaders in Emergency Nursing for 2025
Revolutionizing M&A: Navatar Enhances Deal Management with AI
Investigation of Nutex Health Inc. by Faruqi & Faruqi, LLP
Investigation Launched for Lockheed Martin Investor Claims
Fangzhou Inc. Celebrates Gilead Excellence Award Success
Explore Top Kitchen Flooring Choices with Roman Keim
Investigation Launched Into Semler Scientific Investor Claims
Investors of Charter Communications Face Legal Investigation
State Department's Censorship Practices Under Scrutiny
Investigation into Unicycive Therapeutics Sparks Investor Interest
Impressive Growth Report: CAIXA Economic Performance in 2025
Chongqing Hosts Revolutionary Robotics Competition Showcasing AI Innovations
Minute Media's Strategic Move: Acquiring VideoVerse's AI Technology
Clinical Study Results of Telitacicept at Major Medical Meeting
Celebrating a Decade of Conservation: Fat Bear Week 2025
Zacatecas Silver Corp Secures $3.75M in Private Placement
Investigation of Altimmune: What Investors Need to Know
Kevin O'Leary's Parenting Insights: Balancing Wealth and Family
LifeMD Faces Investigation Amid Alarming Stock Performance
Investigation of LifeMD Raises Investor Concerns
Celebrating 11 Years of Fat Bear Week and Wildlife Impact
Zacatecas Silver Boosts Private Placement to Generate Funds
Aurora Spine Unveils Groundbreaking DEXA-L™ Fusion Device
Denver Celebrates Culinary Excellence with MICHELIN Stars 2025
Purpose Investments Reveals Distributions for Funds in 2025
JLL Income Property Trust Expands Footprint with New Acquisition
Innovative Trade Bridge by Canton Fair Enhances Global Commerce
CARsgen Reports Promising Long-term Findings for Zevor-cel Use
ACM Research Introduces Advanced Technology for Gold Etching
Legal Action Initiated Against RxSight for Misleading Claims
LifeMD Faces Class Action Lawsuit Over Irregularities
Southwest Gas Holdings Announces Exciting Dividend Plans
Marketing Maven Earns Prestigious Top 10 Ranking in 2024